Search

Your search keyword '"Rio, Emmanuel"' showing total 328 results

Search Constraints

Start Over You searched for: Author "Rio, Emmanuel" Remove constraint Author: "Rio, Emmanuel"
328 results on '"Rio, Emmanuel"'

Search Results

58. Abscopal Response in Metastatic Melanoma: Real-World Data of a Retrospective, Multicenter Study

59. Transcatheter arterial chemoembolization (TACE) followed by conformal radiotherapy versus TACE alone for hepatocellular carcinoma: a western controlled trial

60. Séminaire de Probabilités LI

71. The predictive value of treatment response using FDG PET performed on day 21 of chemoradiotherapy in patients with oesophageal squamous cell carcinoma. A prospective, multicentre study (RTEP3)

74. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial

75. Implementación de la Línea de Investigación-Creación en los procesos formativos y académicos de la Corporación Universitaria Adventista

76. Results from the phase I dose-escalation study of the radiation enhancer NBTXR3 for the treatment of HCC and liver metastases.

77. Radiosensitizing Chemotherapy (Irinotecan) with Stereotactic Body Radiation Therapy for the Treatment of Inoperable Liver and/or Lung Metastases of Colorectal Cancer

79. A Phase I dose escalation trial using Intensity-Modulated Radiotherapy with simultaneous integrated boost in Pelvic Chemoradiotherapy for Metastatic Rectal Cancer

86. A phase I dose escalation trial using intensity-modulated radiotherapy with simultaneous integrated boost in pelvic chemoradiotherapy for metastatic rectal cancer

87. Prognostic Impact of Pretherapeutic FDG-PET in Localized Anal Cancer

88. Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer: Final results of PRODIGE 23 phase III trial, a UNICANCER GI trial.

89. Haute Couture or Ready-To-Wear? Tailored Pelvic Radiotherapy for Prostate Cancer Based on Individualized Sentinel Lymph Node Detection

90. Treatment of hepatocellular carcinoma and liver metastases with hafnium oxide nanoparticles activated by SBRT: A phase I/II trial.

95. Stereotactic body radiation therapy for abdominal oligometastases: a biological and clinical review

96. MÉTHODE POUR DÉTERMINER SI UN PATIENT OBTIENDRA UNE RÉPONSE APRÈS UNE RADIOTHÉRAPIE

97. Early toxicity of a phase II trial of combined salvage radiotherapy and hormone therapy in oligometastatic pelvic node relapses of prostate cancer (OLIGOPELVIS GETUG P07)

99. Prostate cancer with oligometastatic relapse: Combining stereotactic ablative radiotherapy and durvalumab, a randomized phase II trial (POSTCARD - GETUG-P13).

100. First-in-class hafnium oxide nanoparticles NBTXR3 in the treatment of liver cancers.

Catalog

Books, media, physical & digital resources